Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeInfrared CamerasICI and Viral Sign a Form a Strategic Alliance

ICI and Viral Sign a Form a Strategic Alliance

January 27, 2021

ICI and Viral Sign strategic alliance will allow both companies to supply advanced screening systems intended to help slow the spread of infectious disease, including COVID-19.

Under the terms of the partnership, ICI will be the exclusive supplier of thermal-camera hardware, including ICI’s flagship FMX400, to Viral Sign’s future installations.  ICI is the supplier of choice to Fortune 500 companies, and to agencies of the U.S. federal government.  ICI’s hardware, which has received 510(k) clearance from the FDA, is renowned for its high quality and market-leading accuracy.

By partnering with Viral Sign, ICI expands and strengthens its distribution footprint, and significantly increases its reach into additional sites of care. The partnership is particularly relevant to employers with significant operational and economic risk due to infectious disease, including senior living, healthcare, food processing, manufacturing, education, and hospitality.

Viral Sign’s proprietary software algorithms help to identify the presence of virus, including COVID-19, in individuals prior to the onset of symptoms. Early identification of the potential for a contagious virus helps to ensure a safe work environment for employees and a safe return of employees to their families at the end of the workday. Viral Sign leverages the power of infrared imaging and an advanced screening algorithm to produce a comprehensive thermal signature of the face.

In real-time, Viral Sign’s advanced screening algorithm assesses the thermal signature across regions of interest in the face to identify patterns consistent with early, presymptomatic influenza-like illness, including COVID-19. Viral Sign represents a significant advance in screening science relative to body temperature or symptom-focused screening platforms.

The ICI/Viral Sign partnership is the result of a shared commitment to helping employers create a “site safe” workplace for employees, customers, and guests.  Working together, ICI and Viral Sign will also continue to develop software platforms that equip their customers to acquire and report real-time, secure insights about workplace safety both on-site and across multiple installations.  These development efforts will enable the acceleration of insights into human health that can transform the use of thermal technology for healthcare and wellness applications.

Gary Strahan, the CEO of ICI commented: “Viral Sign is a true innovator in the use of thermal technology for improvements in public health.  We are proud to be their exclusive supplier, and we look forward to working with Viral Sign to co-develop innovative world-class solutions to public health problems.”

Barry Hix, the CEO of Viral Sign said: “ICI’s name is synonymous with best-in-class accuracy and reliability in thermal-screening technology.  The rich data generated by ICI cameras align perfectly with Viral Sign’s software algorithms, enhancing our ability to provide predictive insights into the health of individuals, workforces, and communities.  We look forward to rolling out our ICI-powered systems into our client base, and to working with ICI on additional technology development.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy